Meijer DK - Search Results

1

Pharmacokinetics of Succinylated Serum Albumin in Wistar Rats and Cynomolgus Monkeys: Implications for Dosage Regimens in the Therapy of HIV Infection.

Swart PJ, Schutten M, Smit C, van Amerongen G, Proost JH, Osterhaus AD, Meijer DK. Swart PJ, et al. Among authors: meijer dk. Drug Deliv. 1996;3(3):165-71. doi: 10.3109/10717549609029446. Drug Deliv. 1996. PMID: 26790912 Free article.

2

The metabolic fate of the Anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats.

Swart PJ, Kuipers ME, Smit C, Beljaars L, Ter Wiel J, Meijer DK. Swart PJ, et al. Among authors: meijer dk. J Drug Target. 2001 Apr;9(2):95-109. doi: 10.3109/10611860108997921. J Drug Target. 2001. PMID: 11697111

3

Prediction of the pharmacokinetics of succinylated human serum albumin in man from in vivo disposition data in animals and in vitro liver slice incubations.

Proost JH, Beljaars L, Olinga P, Swart PJ, Kuipers ME, Reker-Smit C, Groothuis GM, Meijer DK. Proost JH, et al. Among authors: meijer dk. Eur J Pharm Sci. 2006 Feb;27(2-3):123-32. doi: 10.1016/j.ejps.2005.08.014. Epub 2005 Oct 10. Eur J Pharm Sci. 2006. PMID: 16219448

4

Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.

Kamps JA, Swart PJ, Morselt HW, Pauwels R, De Béthune MP, De Clercq E, Meijer DK, Scherphof GL. Kamps JA, et al. Among authors: meijer dk. Biochim Biophys Acta. 1996 Jan 31;1278(2):183-90. doi: 10.1016/0005-2736(95)00218-9. Biochim Biophys Acta. 1996. PMID: 8593275 Free article.

5

An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.

Proost JH, Wierda JM, Meijer DK. Proost JH, et al. Among authors: meijer dk. J Pharmacokinet Biopharm. 1996 Feb;24(1):45-77. doi: 10.1007/BF02353510. J Pharmacokinet Biopharm. 1996. PMID: 8827583

6

Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.

Swart PJ, Beljaars E, Smit C, Pasma A, Schuitemaker H, Meijer DK. Swart PJ, et al. Among authors: meijer dk. J Drug Target. 1996;4(2):109-16. doi: 10.3109/10611869609046269. J Drug Target. 1996. PMID: 8894971

7

Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.

Kuipers ME, Swart PJ, Schutten M, Smit C, Proost JH, Osterhaus AD, Meijer DK. Kuipers ME, et al. Among authors: meijer dk. Antiviral Res. 1997 Jan;33(2):99-108. doi: 10.1016/s0166-3542(96)01005-4. Antiviral Res. 1997. PMID: 9021051

8

The in vitro anti-HIV efficacy of negatively charged human serum albumin is antagonized by heparin.

Swart PJ, Sun CS, Kuipers ME, Asuncion C, Josephs S, Smit C, Meijer DK. Swart PJ, et al. Among authors: meijer dk. AIDS Res Hum Retroviruses. 1997 May 20;13(8):677-83. doi: 10.1089/aid.1997.13.677. AIDS Res Hum Retroviruses. 1997. PMID: 9168236

9

Lactoferrin. Antiviral activity of lactoferrin.

Swart PJ, Kuipers EM, Smit C, Van Der Strate BW, Harmsen MC, Meijer DK. Swart PJ, et al. Among authors: meijer dk. Adv Exp Med Biol. 1998;443:205-13. Adv Exp Med Biol. 1998. PMID: 9781360

10

Mechanism of anti-HIV activity of succinylated human serum albumin.

Kuipers ME, vd Berg M, Swart PJ, Laman JD, Meijer DK, Koppelman MH, Huisman H. Kuipers ME, et al. Among authors: meijer dk. Biochem Pharmacol. 1999 Apr 15;57(8):889-98. doi: 10.1016/s0006-2952(98)00369-4. Biochem Pharmacol. 1999. PMID: 10086322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters